Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,824 public trials 142 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Recruiting

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

NCT06822790

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations: Research Site 21 Bakersfield, California, United States

Research Site 9 Beverly Hills, California, United States

Research Site 11 Canoga Park, California, United States

Research Site 40 Garden Grove, California, United States

View all 255 locations

View Trial Details

Recruiting

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

NCT04941599

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Pemafibrate for Symptomatic ICAS RCT

NCT07562178

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +13 more
Locations: Iwate Medical University Hospital Hizume, Iwate, Japan

Kagoshima Medical Center Kagoshima, Kagoshima-ken, Japan

Kumamoto University Hospital Kumamoto, Japan

Japanese Red Cross Kyoto Daini Hospital Kyoto, Japan

View all 37 locations

View Trial Details

Recruiting

Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants

NCT07629999

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Celerion Coorporate Office Nebraska Lincoln, Nebraska, United States

View Trial Details

Recruiting

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

NCT07477704

Conditions: Body Weight, Dyslipidemias, Hypercholesterolemia, +10 more
Locations: Pinnacle Research Group Anniston, Alabama, United States

Cullman Clinical Trials Cullman, Alabama, United States

Anaheim Clinical Trials Anaheim, California, United States

Cenexel CNS Los Alamitos, California, United States

View all 34 locations

View Trial Details

Recruiting

Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT

NCT07720232

Conditions: Acute Pancreatitis, Hypertriglyceridemia-induced, Digestive System Diseases, Dyslipidemias, +8 more
Locations: Department of Gastroenterology, Zhongshan Hospital, Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

NCT07695597

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

NCT07087184

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemias, +8 more
Locations: UCSF Medical Center at Parnassus San Francisco, California, United States

View Trial Details

Recruiting

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

NCT06451770

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more
Locations: Clinical Study Center Clearwater, Florida, United States

Clinical Study Center Miami Lakes, Florida, United States

Clinical Study Center Port Orange, Florida, United States

Clinical Study Center New York, United States

View all 16 locations

View Trial Details

Recruiting

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

NCT06988462

Conditions: Body Weight, Diabetes, Diabetes Mellitus, +24 more
Locations: Cambridge Health Alliance Sommerville, Massachusetts, United States

View Trial Details